DK0539525T3 - Vitalethein og anvendelse deraf i cellekultur og terapi - Google Patents
Vitalethein og anvendelse deraf i cellekultur og terapiInfo
- Publication number
- DK0539525T3 DK0539525T3 DK91915854T DK91915854T DK0539525T3 DK 0539525 T3 DK0539525 T3 DK 0539525T3 DK 91915854 T DK91915854 T DK 91915854T DK 91915854 T DK91915854 T DK 91915854T DK 0539525 T3 DK0539525 T3 DK 0539525T3
- Authority
- DK
- Denmark
- Prior art keywords
- vitalethein
- therapy
- cell culture
- vitaletheine
- cell
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- 238000002659 cell therapy Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- -1 Vitaletheine Chemical class 0.000 abstract 1
- NXURKZIMAQBJEU-UHFFFAOYSA-N [3-[2-[2-[3-(carboxyamino)propanoylamino]ethyldisulfanyl]ethylamino]-3-oxopropyl]carbamic acid Chemical compound OC(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(O)=O NXURKZIMAQBJEU-UHFFFAOYSA-N 0.000 abstract 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-N carbazic acid Chemical class NNC(O)=O OWIUPIRUAQMTTK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003915 cell function Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 239000003104 tissue culture media Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54910590A | 1990-07-06 | 1990-07-06 | |
| US54944090A | 1990-07-06 | 1990-07-06 | |
| US54943890A | 1990-07-06 | 1990-07-06 | |
| PCT/US1991/004726 WO1992000955A1 (en) | 1990-07-06 | 1991-07-08 | Vitaletheine and use in cell culture and therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0539525T3 true DK0539525T3 (da) | 2000-04-10 |
Family
ID=27415550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91915854T DK0539525T3 (da) | 1990-07-06 | 1991-07-08 | Vitalethein og anvendelse deraf i cellekultur og terapi |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0539525B1 (enExample) |
| JP (1) | JP3259960B2 (enExample) |
| AT (1) | ATE186048T1 (enExample) |
| AU (1) | AU655598B2 (enExample) |
| DE (1) | DE69131752T2 (enExample) |
| DK (1) | DK0539525T3 (enExample) |
| ES (1) | ES2139580T3 (enExample) |
| GR (1) | GR3031801T3 (enExample) |
| WO (1) | WO1992000955A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1018877A4 (en) * | 1995-10-17 | 2000-08-09 | Dovetail Technologies Inc | LOW MOLECULAR WEIGHT STIMULANTS OF BONE MARROW AND IMMUNE SYSTEM CELLS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552765A (en) * | 1982-05-14 | 1985-11-12 | Santen Pharmaceutical Co., Ltd. | Aletheine derivatives |
| EP0538330B1 (en) * | 1990-07-06 | 1995-10-11 | University Of New Mexico | Beta-alethine use in cell culture and therapy |
-
1991
- 1991-07-08 AT AT91915854T patent/ATE186048T1/de not_active IP Right Cessation
- 1991-07-08 JP JP51462891A patent/JP3259960B2/ja not_active Expired - Fee Related
- 1991-07-08 AU AU85008/91A patent/AU655598B2/en not_active Ceased
- 1991-07-08 EP EP91915854A patent/EP0539525B1/en not_active Expired - Lifetime
- 1991-07-08 DK DK91915854T patent/DK0539525T3/da active
- 1991-07-08 ES ES91915854T patent/ES2139580T3/es not_active Expired - Lifetime
- 1991-07-08 WO PCT/US1991/004726 patent/WO1992000955A1/en not_active Ceased
- 1991-07-08 DE DE69131752T patent/DE69131752T2/de not_active Expired - Fee Related
-
1999
- 1999-11-10 GR GR990402894T patent/GR3031801T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0539525A4 (enExample) | 1994-01-12 |
| GR3031801T3 (en) | 2000-02-29 |
| JP3259960B2 (ja) | 2002-02-25 |
| EP0539525B1 (en) | 1999-10-27 |
| ES2139580T3 (es) | 2000-02-16 |
| DE69131752T2 (de) | 2000-06-29 |
| AU655598B2 (en) | 1995-01-05 |
| WO1992000955A1 (en) | 1992-01-23 |
| AU8500891A (en) | 1992-02-04 |
| ATE186048T1 (de) | 1999-11-15 |
| DE69131752D1 (de) | 1999-12-02 |
| JPH06500106A (ja) | 1994-01-06 |
| EP0539525A1 (en) | 1993-05-05 |
| HK1014367A1 (en) | 1999-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1242578T3 (da) | Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin | |
| ATE347585T1 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
| BR9910251A (pt) | Estimulação hematopoiética | |
| BR0210599A (pt) | Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril | |
| HUP0500477A2 (hu) | Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával | |
| ES2074867T3 (es) | Derivados de quinazolina para potenciar la actividad antitumoral. | |
| AR241314A1 (es) | Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional. | |
| ES8602112A1 (es) | Procedimiento para preparar un polipeptido ciclico | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| FI920430A0 (fi) | Benzyloxifenylderivator. | |
| ATE236638T1 (de) | Neue verwendung von prostaglandinen | |
| DE3850778D1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
| DK0539525T3 (da) | Vitalethein og anvendelse deraf i cellekultur og terapi | |
| DK0538330T3 (da) | Beta-Alethin-anvendelse til celledyrkning og terapi | |
| ATE124262T1 (de) | Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung. | |
| ES471769A1 (es) | Procedimiento para la obtencion de penicilinas | |
| DE69021128D1 (de) | Interleukin-1-Inhibitor. | |
| ES2154290T3 (es) | Estimulacion de la diferenciacion celular por sindecano. | |
| PT883406E (pt) | Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente | |
| FR2835429B1 (fr) | Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique | |
| EP0248217A3 (en) | Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor | |
| ES2057528T3 (es) | Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen. | |
| ES8801624A1 (es) | Procedimiento para preparar disulfuros heterociclicos | |
| ATE69551T1 (de) | Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren. | |
| GR3024709T3 (en) | Novel cytarabine derivatives, their production and use |